Summary
Estrogen receptor (ER) was measured on two or more specimens taken from each of 53 patients with carcinoma of the breast (18 also had progesterone receptor analyzed). Among the 35 patients who had no interval therapy, 27 patients had repeated tests within one month, and only two had reversal of ER results. Among the eight patients who had ER tests 9–36 months apart, four of five ER + lesions (7 + fmol/mg cytosol protein) had ER − metastasis. Among the 18 patients who received systemic therapy, three of ten ER + became ER −, while two of ten ER − became ER +. Our data and reports in the literature are summarized, showing that about 20% of receptor studies among multiple samples are different even when patients received no interval therapy. In asynchronous studies, it is more likely to have ER positive change to negative than vice versa (31% vs 12%). Interval chemotherapy or endocrine therapy tends to increase the occurrence of ER negative relapse among patients with ER positive tumors.
References
Jensen EV, Block GE, Smith S, Kyser K, DeSombre ER: Estrogen receptors and breast cancer response to adrenalectomy. Nat Cancer Inst Monogr 34: 55–70, 1971
Jensen EV: Estrogen receptors in human cancers. J Am Med Assoc 238: 59–60, 1977
McGuire WL, Horwitz KB, Pearson OH, Segaloff A: Current status of estrogen and progesterone receptors in breast cancer. Cancer 39: 2934–2947, 1977
Jensen EV, Polley TZ, Smith S, Block E, Ferguson DJ, DeSombre ER: Prediction of hormone dependency in human breast cancer.In WL McGuire, PP Carbone, and EP Vollmer (eds): Estrogen Receptors in Human Breast Cancer, New York, Raven Press, 1975, pp 37–56
Rosen PP, Menenedez-Botet CJ, Urban JA, Fracchia A, Schwartz MK: Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancer. Cancer 39: 2194–2200, 1977
Kiang DT, Kennedy BJ: Factors affecting estrogen receptors in breast cancer. Cancer 40: 1571–1576, 1977
Lee Y-TN, Markland FS: Steroid receptors study in breast carcinoma. Med Ped Oncol 5: 153–166, 1978
Webster DJT, Bronn DG, Minton JP: Estrogen receptor levels in multiple biopsies from patients with breast cancer. Am J Surg 136: 337–338, 1978
Brennan MJ, Donegan WL, Appleby DE: The variability of estrogen receptors in metastatic breast cancer. Am J Surg 137: 260–262, 1979
Hoehn JL, Plotka ED, Dickson KB: Comparison of estrogen receptor levels in primary and regional metastatic carcinoma of the breast. Ann Surg 190: 69–71, 1979
Allegra JC, Barlock A, Huff KK, Lippman ME: Changes in multiple or sequential estrogen receptor determinations in breast cancer. Cancer 45: 792–794, 1980
Skinner LG, Barnes DM, Ribeiro GG: The clinical value of multiple steroid receptor assays in breast cancer management. Cancer 46: 2939–2945, 1980
King RJB: Analysis of estradiol and progesterone receptors in early and advanced breast tumors. Cancer 46: 2818–2821, 1980
Namer M, Lalanne C, Baulieu EE: Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer. Cancer Res 40: 1750–1752, 1980
Waseda N, Kato Y, Imura H, Kurata M: Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer. Cancer Res 41: 1984–1988, 1981
Rosenthal LJ: Discrepant estrogen receptor protein levels according to surgical technique. Am J Surg 138: 680–681, 1979
Newsome JF, Avis FP, Hammond JE, Sherwood S: Sampling procedures in estrogen receptor determinations. Ann Surg 193: 549–554, 1981
Muschenheim F, Furst JL, Bates HA: Increased incidence of positive tests for estrogen binding in mammary carcinoma specimens transported in liquid nitrogen. Am J Clin Path 70: 780–782, 1978
Lesser ML, Rosen PP, Senie RT, Duthie K, Menenedez-Botet C, Schwartz MK: Estrogen and progesterone receptors in breast carcinoma: Correlations with epidemiology and pathology. Cancer 48: 299–309, 1981
Terenius L, Johansson H, Rimsten A, Thoren L: Malignant and benign human mammary disease: Estrogen binding in relation to clinical data. Cancer 33: 1364–1368, 1974
Silvestrini R, Daidone MG, Di Fronzo G: Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer 44: 665–670, 1979
Meyer JS, Rao BR, Stevens SC, White WL: Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication. Cancer 40: 2290–2298, 1977
Meyer JS, Lee JY: Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival. Cancer Res 40: 1890–1896, 1980
Kute TE, Muss HB, Anderson D, Crumb K, Miller B, Burns D, Dube LA: Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer. Cancer Res 41: 3524–2529, 1981
Collings JR, Levin J, Savage N: Racial differences in oestrogen receptor and peroxidase status of human breast cancer tissue. S Afr Med J 57: 444–446, 1980
Papatestas AE, Panveliwalla D, Pertsemlidis D, Mulvihill M, Aufses AH Jr: Association between estrogen receptors and weight in women with breast cancer. J Surg Oncol 13: 177–180, 1980
Daniell, HW: Estrogen receptors, breast cancer, and smoking. New Eng J Med 302: 1478, 1980
Hrushesky W, Teslow T, Halberg F, Kiang D, Kennedy BJ: Temporal components of predictable variability along the 1-year scale in estrogen receptor concentration of primary human breast cancer. ASCO Abstracts p. 331, March 1979
DeSombre ER, Jensen EV: Estrophilin assays in breast cancer: Quantitative features and application to the mastectomy specimen. Cancer 46: 2783–2788, 1980
McGuire WL, Pearson OH, Segaloff A: Predicting hormone responsiveness in human breast cancer.In WL McGuire, PP Carbone and EP Vollmer (eds): Estrogen receptors in human breast cancer. Raven Press, New York, 1975, pp 17–30
Anderson KM, Bonomi P, Marogil M, Hendrickson C, Economou S: Comparison of dextran-coated charcoal and sucrose density gradient analyses of estrogen and progesterone receptors in human breast cancer. Cancer Res 40: 4127–4132, 1980
Sarrif AM, Durant JR: Evidence that estrogen-receptornegative, progesterone-receptor-positive breast and ovarian carcinomas contain estrogen receptor. Cancer 48: 1215–1220, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, YT.N.(. Variability of steroid receptors in multiple biopsies of breast cancer: Effect of systemic therapy. Breast Cancer Res Tr 2, 185–193 (1982). https://doi.org/10.1007/BF01806455
Issue Date:
DOI: https://doi.org/10.1007/BF01806455